26
Views
24
CrossRef citations to date
0
Altmetric
Research Article

N-Acetyltransferase-2, Glutathione S-Transferase M1, Alcohol Dehydrogenase, and Cytochrome P450IIE1 Genotypes in Alcoholic Liver Cirrhosis: A Case?Control Study

Pages 303-307 | Published online: 08 Jul 2009

References

  • Smith M. Genetics of human alcohol and aldehyde dehydrogenase. Adv Hum Genet 1986;15:249–90.
  • Yamauchi M, Maezawa Y, Toda G, Suzuki H, Sakurai S. Association of a restriction fragment length polymorphism in the alcohol dehydrogenase 2 gene with Japanese alcoholic liver cirrhosis. J Hepatol 1995;23: 519–23.
  • Tsutsumi M, Takada A, Jian-Song W. Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 1994;107: 1430–5.
  • Maezawa Y, Yamauchi M, Toda G. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to alcohol liver cirrhosis. Am J Gastroenterol 1994;89: 561–5.
  • Bosron WF, Li TK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases and their relationship to alcohol metabolism and alcoholism. Hepatology 1986;6:502–10.
  • Bosron WF, Lumeng L, Li TK. Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease. Mol Aspect Med 1988;10:147–58.
  • Day CP, Bashir R, James OFW, Bassendine MF, Crabb DW, Thomasson HR, et al. Investigation of the role of polymorphism at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology 1991;14:798–801.
  • Sherman DI, Ward RJ, Warren-Perry M, Williams R, Peters TJ. Association of restriction fragment length polymorphism in alcohol dehydrogenase 2 gene with alcohol induced liver damage. Br Med J 1993;307: 1388–90.
  • Chao YC, Liou SR, Chung YY, Tang HS, Hsu CT, Li TK, et al. Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology 1994; 19:360–6.
  • Blum M, Demierre A, Grant DM, Heim M, Meyer UA. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci USA 1991;88: 5237–41.
  • Hein DW, Doll MA, Rustan TD, Ferguson RJ. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions. Cancer Res 1995;55:3531–6.
  • Hein DW, Ferguson RJ, Doll MA, Rustan TD, Gray K. Molecular genetics of human polymorphic N-acetyltranferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet 1994;3: 729–34.
  • Cascorbi I, Drakoulis N, Brockmoller J, Maurer A, Sperling K, Roots I. Arylamine N-acetyltransferase (NAT2) mutations andtheir allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 1995;57:581–92.
  • Risch A, Wallace DMA, Bathers S, Sim E. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 1995;4:231–6.
  • Ilett KF, David BM, Detchon P. Acetylation phenotype in colorectal cancer. Cancer Res 1987;47:1466–9.
  • Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. Cigarette smoking, N-Acetyltransferase 2 genetic polymorphisms, and breast cancer. JAMA 1996;276: 1494–501.
  • Gonzalez MV, Pello MF, Suárez C, Coto E. DNA polymorphisms at the cytochrome P450IIE1, glutathione S-transferase M1, and N-acetyltranferase-2 genes in the susceptibility to develop head and neck cancer. J Clin Pathol 1998;51: 294–8.
  • Hein DW. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 1988;948:37–66.
  • Hayes JD, Wolf CR. Molecular mechanisms of drug resistance. Biochem J 1990;272:281–95.
  • Comstock NE, Sanderson BJS, Claflin G, Henner WD. GSTM1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res 1990;18:3670.
  • Heckbert SR, Weiss NS, Horning SK, Eaton DC, Motulsky A. Glutathione S-transferase and epoxide hydrolase activity in human leucocytes in relation to risk of lung cancer and other smoking related cancers. J Natl Cancer Inst 1992;84:414–22.
  • Seidegard J, Pero RW, Miller DW, Beattle EJ. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986;7:751–3.
  • Coutelle C, Ward PJ, Fleury B, Quattrocchi P, Chambrin H, Iron A, et al. Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum Genet 1997;99:319–25.
  • Miller SA, Dykes DD, Polesky HFA. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
  • Watanabe J, Hayashi SI, Nakachi K, Imai K, Suda Y, Sekine T, et al. PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res 1990;18:7194.
  • Hayashi SI, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5'-flanking region change the transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991;110: 559–65.
  • Yoshida A, Hsu LC, Yasunami M. Genetics of human alcoholmetabolizing enzymes. Prog Nucleic Acid Res Mol Biol 1991; 40:255–87.
  • Carr LG, Hartleroad JY, Liang Y, Mendenhall C, Moritz T, Thomasson H. Polymorphism at the P450IIE1 locus is not associated with alcoholic liver disease in Caucasian men. Alcohol Clin Exp Res 1995;19:182–4.
  • Couzigou P, Fleury B, Groppi A, Cassaigne A, Begueret J, Iron A. Genotyping study of alcohol dehydrogenase class I polymorphism in French patients with alcoholic cirrhosis. Alcohol Alcoholism 1990;25:263–6.
  • Harada S, Abei M, Tanaka N, Agarwai DP, Goedde HW. Liver glutathione S-transferase polymorphism in Japanese and its pharmacogenetic importance. Hum Genet 1987;75:322–5.
  • Baranov VS, Ivaschenko T, Bakay B, Aseev M, Belotserkovskaya R, Baranova H, et al. Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases. Hum Genet 1996;97:516–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.